HLA-DQB1 and metabolic syndrome: Among the patients with NT2, our results indicated that patients who were HLA-DQB1*06:02 positive had a significantly higher incidence of hypertension and dyslipidemia than that had by those who were HLA-DQB1*06:02 negative.